Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY) Cut to “Hold” at Jefferies Financial Group

Jefferies Financial Group downgraded shares of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY) from a buy rating to a hold rating in a research note published on Monday, MarketBeat.com reports.

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Price Performance

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München stock opened at $10.20 on Monday. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.20. The firm has a market capitalization of $13.92 billion, a P/E ratio of 13.57, a PEG ratio of 0.69 and a beta of 1.02. The business has a 50-day moving average of $52.65 and a 200-day moving average of $49.71. Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München has a 1 year low of $7.86 and a 1 year high of $11.14.

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY) last issued its quarterly earnings data on Thursday, August 8th. The financial services provider reported $1.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.07. The firm had revenue of $16.10 billion for the quarter. On average, equities analysts anticipate that Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München will post 5.75 EPS for the current year.

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Company Profile

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. It also offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, MIRA digital suite, MIRA POS, MIRApply insured and physician, claims risk adjustment, CLARA plus, data analytics, underwriting and claims, medical research, capital management, and health market.